Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Fish

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
American Journal of Respiratory Cell and Molecular Biology|March 2, 2013
An IL-4/IL-13 dual antagonist reduces lung inflammation, airway hyperresponsiveness, and IgE production in miceMarion T Kasaian, Kimberly Marquette, Susan Fish, et al.
Journal of Medicinal Chemistry|February 12, 2014
Discovery of isoquinolinone indole acetic acids as antagonists of chemoattractant receptor homologous molecule expressed on Th2 cells (CRTH2) for the treatment of allergic inflammatory diseasesNeelu Kaila, Bruce Follows, Louis Leung, et al.
Immunology|May 17, 2014
Therapeutic activity of an interleukin-4/interleukin-13 dual antagonist on oxazolone-induced colitis in miceMarion T Kasaian, Karen M Page, Susan Fish, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 15, 2014
Safety and effectiveness of bevacizumab-containing treatment for non-small-cell lung cancer: final results of the ARIES observational cohort studyThomas J Lynch, David R Spigel, Julie Brahmer, et al.
Journal of Medicinal Chemistry|September 4, 2009
Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthmaWei Li, Jianchang Li, Yuchuan Wu, et al.
Bioorganic & Medicinal Chemistry Letters|December 14, 2011
Discovery of potent and selective matrix metalloprotease 12 inhibitors for the potential treatment of chronic obstructive pulmonary disease (COPD)Yuchuan Wu, Jianchang Li, Junjun Wu, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 11, 2025
Real-World Treatment Patterns and Clinical Outcomes in Patients With Multiple Myeloma Previously Treated With Lenalidomide and an Anti-CD38 Monoclonal AntibodyKarthik Ramasamy, Ravi Vij, David Kuter, et al.
Scientific Reports|December 18, 2025
Ligand non-competitive GITR antibody prevents formation of the obligatory signal-triggering GITRL: GITR stoichiometryJing Yan, Jessica Min-DeBartolo, Ching-Shin Huang, et al.
Journal of Medicinal Chemistry|August 14, 2020
Discovery of Tyrosine Kinase 2 (TYK2) Inhibitor (PF-06826647) for the Treatment of Autoimmune DiseasesBrian S Gerstenberger, Catherine Ambler, Eric P Arnold, et al.
Journal of Medicinal Chemistry|August 22, 2018
Discovery of 3-Cyano- N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1 H-pyrrolo[2,3- b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse AgonistMark E Schnute, Mattias Wennerstål, Jennifer Alley, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
American Journal of Respiratory Cell and Molecular Biology|March 2, 2013
An IL-4/IL-13 dual antagonist reduces lung inflammation, airway hyperresponsiveness, and IgE production in miceMarion T Kasaian, Kimberly Marquette, Susan Fish, et al.
Journal of Medicinal Chemistry|February 12, 2014
Discovery of isoquinolinone indole acetic acids as antagonists of chemoattractant receptor homologous molecule expressed on Th2 cells (CRTH2) for the treatment of allergic inflammatory diseasesNeelu Kaila, Bruce Follows, Louis Leung, et al.
Immunology|May 17, 2014
Therapeutic activity of an interleukin-4/interleukin-13 dual antagonist on oxazolone-induced colitis in miceMarion T Kasaian, Karen M Page, Susan Fish, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 15, 2014
Safety and effectiveness of bevacizumab-containing treatment for non-small-cell lung cancer: final results of the ARIES observational cohort studyThomas J Lynch, David R Spigel, Julie Brahmer, et al.
Journal of Medicinal Chemistry|September 4, 2009
Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthmaWei Li, Jianchang Li, Yuchuan Wu, et al.
Bioorganic & Medicinal Chemistry Letters|December 14, 2011
Discovery of potent and selective matrix metalloprotease 12 inhibitors for the potential treatment of chronic obstructive pulmonary disease (COPD)Yuchuan Wu, Jianchang Li, Junjun Wu, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 11, 2025
Real-World Treatment Patterns and Clinical Outcomes in Patients With Multiple Myeloma Previously Treated With Lenalidomide and an Anti-CD38 Monoclonal AntibodyKarthik Ramasamy, Ravi Vij, David Kuter, et al.
Scientific Reports|December 18, 2025
Ligand non-competitive GITR antibody prevents formation of the obligatory signal-triggering GITRL: GITR stoichiometryJing Yan, Jessica Min-DeBartolo, Ching-Shin Huang, et al.
Journal of Medicinal Chemistry|August 14, 2020
Discovery of Tyrosine Kinase 2 (TYK2) Inhibitor (PF-06826647) for the Treatment of Autoimmune DiseasesBrian S Gerstenberger, Catherine Ambler, Eric P Arnold, et al.
Journal of Medicinal Chemistry|August 22, 2018
Discovery of 3-Cyano- N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1 H-pyrrolo[2,3- b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse AgonistMark E Schnute, Mattias Wennerstål, Jennifer Alley, et al.
Pageof 2